Professional Documents
Culture Documents
Pedia Drug Study
Pedia Drug Study
GENERIC Inhibits toxin A- mediated INDICATIONS CNS Assess patient for abdominal
ENTEROL diarrhea, intestinal inflammation & Indicated in the specific and Hypotension, Fever, Nausea, distention, presence of bowel
histological damage by reducing symptomatic treatment of bacterial Emesis, Headache sounds, and usual pattern of
BRAND toxin A- receptor binding or protozoal diarrhea and enteritis bowel function.
SACCHAROMYCES caused by susceptible GI Assess color, consistency, and
BOULARDII organisms. Enterol products are Colitis, Bloating, Constipation, amount of stool produced.
well tolerated, have a very low Flatulence Instruct patient SO to take as
CLASSIFICATION SOURCE: incidence of adverse reactions. directed.
GU
THERAPEUTIC Hossain MN, Afrin S, Humayun S, CONTRAINDICATION Proctitis, Anal pruritus,
ANTIDIARRHEALS Ahmed MM, Saha BK. Front Nutr. In general M.O. drugs, tyramine Staphylococcic enteritis
2020; 7:27. Epub 2020 Apr 3. containing foods & indirectly
PHARMACOLOGIC acting sympathomimetic amines MUSCULOSKELETAL
PHARMACOKINETICS are contraindicated or should be Arthralgia
used with caution in patients
DOSAGE receiving enterol RESPIRATORY
2. 5- 5.0 ml Dyspnea
ROUTE SKIN
ORAL Vesicular morbilliform rash,
Flushing
SKIN
Rash